Since STAT3 inhibits NF-κB-mediated anti-tumor immunity45, a previous study explored whether the activation of NF-κB suppresses tumor progression in STAT3-silencing hepatocellular carcinoma46. The gene discussed is NFKB1; the disease is neoplasm.